Clinics in Tampa, St. Petersburg, Clearwater and Sarasota advertise weight loss injections, and so do telehealth services that ship to Florida. The offers look different, but most come down to two medicines and a monthly fee. Knowing what the medicine itself costs, how the price changes as the dose goes up, and what your Florida coverage will pay for makes the offers much easier to compare.
This guide walks through the injections on the market, what the first three months cost, how to get coverage through an employer plan, Florida Medicaid or Medicare, what to ask a clinic, and the studies enrolling in St. Petersburg.
Studies enrolling across Tampa Bay
See weight loss, fatty liver, diabetes and sleep apnea studies near Tampa and St. Petersburg, and apply in about 5 minutes.
What weight loss injections are on the market
Most weight loss injections you will see advertised contain semaglutide or tirzepatide. Semaglutide is sold as Wegovy for weight management and as Ozempic for type 2 diabetes. Tirzepatide is sold as Zepbound for weight management and as Mounjaro for type 2 diabetes.
Both are injected once a week, and both start at a low dose that goes up every four weeks so the stomach can adjust: Wegovy from 0.25 mg toward 2.4 mg, and Zepbound from 2.5 mg toward a maintenance dose of 5 to 15 mg. The slow start is also why the price you pay changes over the first months.
Wegovy has two more approvals: lowering heart attack and stroke risk in adults with heart disease and overweight or obesity, and treating MASH with moderate to advanced liver scarring. Zepbound is also approved for moderate to severe obstructive sleep apnea in adults with obesity. A clinic can prescribe Ozempic or Mounjaro for weight loss off label, but insurers usually pay for them only with a diabetes diagnosis.
For weight management, both injections are approved for adults with a BMI of 30 or higher, or 27 or higher with a condition such as high blood pressure or type 2 diabetes. If you would rather take a pill, Wegovy also comes as a daily tablet, and Foundayo (orforglipron) is a daily GLP-1 pill approved in April 2026.
What the first three months cost
The manufacturers sell both injections directly to people paying cash, at the same price in Florida as in other states. Because the dose rises every four weeks, the price usually rises with it. As of November 2026:
- Zepbound through LillyDirect (vials or KwikPen): the first three fills, at 2.5 mg, 5 mg and 7.5 mg, cost $299, $399 and $449, about $1,150 in total, if each refill is completed within 45 days. Every dose from 7.5 mg up costs $449.
- Wegovy through NovoCare Pharmacy: new patients pay $199 for each of the first two fills, 0.25 mg and 0.5 mg, through December 31, 2026, then $349 a month at every dose up to 2.4 mg. That is about $750 for the first three fills.
A clinic adds its own fee for visits and follow-up, either on top of the medicine or folded into one monthly price. Ask for the price at the dose you will be on by month four, not only the first month.
How to get weight loss injections through insurance in Florida
Coverage depends on the plan, so start there before you book anything. If your employer plan dropped coverage recently, you are not alone: many plans tightened their rules in 2025 and 2026.
- Check whether the plan covers weight management at all, and whether Wegovy and Zepbound are on its drug list.
- Ask what prior authorization needs: usually your BMI, a weight-related condition, and sometimes notes on past attempts to lose weight.
- Ask whether a diagnosis you already have changes the answer. Plans that exclude weight loss often still cover Zepbound for moderate to severe sleep apnea, or Ozempic and Mounjaro for type 2 diabetes.
- If the request is denied, ask your prescriber whether an appeal makes sense.
Florida Medicaid
Florida Medicaid coverage depends on your plan, so ask yours directly. As one example, the policy of Aetna Better Health of Florida, in effect from September 2026, lists weight loss alone as an excluded benefit but covers Wegovy for adults who have had a heart attack, stroke or similar heart event, or who have MASH with moderate to advanced scarring, and Zepbound for moderate to severe sleep apnea with a BMI of 30 or higher, each with prior approval.
Medicare
Many people in Tampa Bay will go through Medicare. In Pinellas County, home to St. Petersburg and Clearwater, 27 percent of residents are 65 or older, compared with about 18 percent nationwide, according to the Census Bureau.
Since July 1, 2026, the Medicare GLP-1 Bridge has covered Wegovy (pill or injection), the Zepbound KwikPen and Foundayo for weight loss for people with a Part D plan. It runs through December 31, 2027.
- To qualify, you need a BMI of 35 or higher, a BMI of 30 or higher with heart failure, uncontrolled high blood pressure or kidney disease, or a BMI of 27 or higher with prediabetes or a past heart attack, stroke or peripheral artery disease.
- Your prescriber submits the prior authorization. Once approved, you pay $50 a month at the pharmacy, whatever the dose.
- If you take Ozempic or Mounjaro for type 2 diabetes, or Zepbound for sleep apnea, the Bridge does not apply, and your regular Part D plan sets the price.
- Extra Help, the Medicare program that lowers drug costs for people with limited income, cannot be applied to the $50 copay.
How to choose a weight loss injection clinic in Tampa Bay
A good clinic will be able to answer these questions plainly:
- Who prescribes the medicine, and will they review my medical history and blood work first?
- Is it the FDA-approved brand from a pharmacy, or a compounded version?
- What will I pay per month at each dose, including visits?
- Who do I contact about side effects, and how quickly?
- What is the plan if my weight stalls, or if I need to stop? See not losing weight on Ozempic or Wegovy.
Two answers should make you pause. A clinic that calls its compounded semaglutide or tirzepatide "the same as" Wegovy or Zepbound is describing something the FDA has said cannot be marketed that way; compounded versions are not FDA-approved. And vials labeled "research use only" or sold as "research peptides" are not meant for people at all.
Studies enrolling in St. Petersburg
If you cannot get a prescription or cannot afford one, two large Eli Lilly studies enroll at a research site in St. Petersburg, and other studies are open across Tampa Bay. The medicine being tested and the study visits are typically provided at no cost, and many studies help with travel. Every weight loss study on our site is listed on our weight loss clinical trials page, which you can filter by city.
Overweight, not obese, with borderline lab results
A phase 3 study of orforglipron, the GLP-1 pill sold as Foundayo, is testing whether starting earlier delays type 2 diabetes and other weight-related conditions. It is open to adults with a BMI of 25 to 29.9, a waist at least half their height, and prediabetes, borderline blood pressure or borderline cholesterol. People with diabetes, a diagnosis of high blood pressure or high cholesterol, or a weight loss medicine in the past six months cannot join. Every group takes orforglipron for part of the study. See the orforglipron study.
Fatty liver with scarring
If a FibroScan or MRI has shown fat and stiffness in your liver, SYNERGY-Outcomes is comparing tirzepatide and the investigational medicine retatrutide with placebo over about four years. Adults with liver fat of 8 percent or more, a FibroScan reading of 10 to just under 20 kPa and a BMI of 25 or higher can apply, including people with type 2 diabetes whose A1C is 10 percent or lower. See SYNERGY-Outcomes, or read our guide to fatty liver treatment options.
Sleep apnea and CPAP that did not work
Adults with obstructive sleep apnea and a BMI of 27 or higher who could not tolerate CPAP can apply to studies enrolling in Tampa Bay. See the sleep apnea studies, or read about CPAP alternatives.
Type 2 diabetes
Investigational GLP-1 pills are being tested in adults with type 2 diabetes, including people with an A1C between 7 and 10.5 percent and people who take only metformin or no diabetes medicine yet. Studies for an A1C of 7 to 10.5 percent and studies for people on metformin only or no medicine.
Your safety comes first, but no study is risk-free. Each study is reviewed by an independent ethics board, and you can stop taking part whenever you choose. Many weight loss studies use a placebo for some participants, so ask how the study is designed before you agree; our guide to informed consent explains what you will be told.
Common questions
What weight loss injections are there on the market? The main ones are Wegovy (semaglutide) and Zepbound (tirzepatide), both weekly injections approved for weight management. Ozempic and Mounjaro contain the same medicines but are approved for type 2 diabetes.
How much do weight loss injections cost in Tampa for the first few months? Buying from the manufacturer, the first three fills of Zepbound cost about $1,150 and the first three fills of Wegovy about $750 for new patients, as of November 2026. A clinic adds its own fee for visits.
How do I get weight loss injections through insurance? Ask your plan whether it covers weight management, what prior authorization requires, and whether it covers the medicine for a condition you already have, such as sleep apnea or type 2 diabetes. Your prescriber then submits the paperwork.
Does Florida Medicaid cover Wegovy or Zepbound? It depends on your plan. One Florida Medicaid plan's 2026 policy excludes weight loss alone but covers Wegovy after a heart attack or stroke or for MASH, and Zepbound for moderate to severe sleep apnea, with prior approval.
Does Medicare cover weight loss injections? Through the Medicare GLP-1 Bridge, people with Part D who meet the BMI criteria pay $50 a month for Wegovy, the Zepbound KwikPen or Foundayo, from July 1, 2026, through December 31, 2027.
How often are weight loss injections given? Wegovy and Zepbound are injected once a week. The dose starts low and goes up every four weeks until you reach the dose your prescriber chooses.
Do weight loss study participants get paid? Some studies offer compensation for time and travel, and study related care is typically provided at no cost to participants. Compensation varies by trial and is always described during the informed consent process before you agree to anything.
